Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Standard tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detect the presence of viral RNA using real-time reverse transcription (rRT)-PCR. Recently, convenient, rapid, and relatively inexpensive SARS-CoV-2 antigen (Ag) detection methods have been developed. The STANDARD Q COVID-19 Ag test (SD Biosensor, Inc., Suwon, Korea) is a rapid immunochromatography test that qualitatively detects the nucleocapsid protein of SARS-CoV-2 using gold conjugated antibodies. We evaluated its performance in comparison with that of Allplex 2019-nCoV Assay (Seegene, Seoul, Korea) in a retrospective case-control study using residual samples. The sensitivity and specificity of the STANDARD Q COVID-19 Ag test were 89.2% (58/65) and 96.0% (96/100), respectively. Cycle threshold (Ct) values for the three target SARS-CoV-2 genes (envelope, RNA-dependent RNA polymerase, and nucleocapsid genes) included in Allplex 2019-nCoV Assay were significantly lower in Ag test-positive patients than in Ag test-negative patients (P<0.001). The Ag test sensitivity was higher in samples with Ct≤30 and those collected one to five days post symptom onset. In conclusion, the STANDARD Q COVID-19 Ag test can serve as an alternative in high-prevalence settings, when the low sensitivity is compensated or when rRT-PCR tests are limited.
Abstract
Standard tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detect the presence of viral RNA using real-time reverse transcription (rRT)-PCR. Recently, convenient, rapid, and relatively inexpensive SARS-CoV-2 antigen (Ag) detection methods have been developed. The STANDARD Q COVID-19 Ag test (SD Biosensor, Inc., Suwon, Korea) is a rapid immunochromatography test that qualitatively detects the nucleocapsid protein of SARS-CoV-2 using gold conjugated antibodies. We evaluated its performance in comparison with that of Allplex 2019-nCoV Assay (Seegene, Seoul, Korea) in a retrospective case-control study using residual samples. The sensitivity and specificity of the STANDARD Q COVID-19 Ag test were 89.2% (58/65) and 96.0% (96/100), respectively. Cycle threshold (Ct) values for the three target SARS-CoV-2 genes (envelope, RNA-dependent RNA polymerase, and nucleocapsid genes) included in Allplex 2019-nCoV Assay were significantly lower in Ag test-positive patients than in Ag test-negative patients (P<0.001). The Ag test sensitivity was higher in samples with Ct≤30 and those collected one to five days post symptom onset. In conclusion, the STANDARD Q COVID-19 Ag test can serve as an alternative in high-prevalence settings, when the low sensitivity is compensated or when rRT-PCR tests are limited.
참고문헌 (19)
- Zhou P, "A pneumonia outbreak associated with a new coronavirus of probable bat origin", Nature, 579, pp.270~273 (2020)
- "Naming the coronavirus disease (COVID-19) and the virus that causes it" (2020)[URL]
- "WHO Coronavirus Disease (COVID-19) Dashboard" (2021)[URL]
- "Diagnostic testing for SARS-CoV-2" (2020)[URL]
- 김영진, "COVID-19 Testing in South Korea: Current Status and the Need for Faster Diagnostics", Annals of Laboratory Medicine, 40(5), pp.349~350 (2020), 대한진단검사의학회[DOI]
- "SARS-CoV-2 diagnostic pipeline (continuously updated)" (2021)[URL]
- Huh Hee Jae, "Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea", Annals of Laboratory Medicine, 41(2), pp.225~229 (2021), 대한진단검사의학회[DOI]
- Diao B, "Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection", Clin Microbiol Infect, 27, pp.289~ (2020)
- Cerutti F, "Urgent need of rapid tests for SARS CoV-2 antigen detection : Evaluation of the SD-Biosensor antigen test for SARS-CoV-2", J Clin Virol, 132, pp.104654~ (2020)
- Jääskeläinen AE, "Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection", J Clin Virol, 137, pp.104785~ (2021)
- Mak GCK, "Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2", J Clin Virol, 134, pp.104712~ (2021)
- Lee Jaehyeon, "Clinical Performance of the Standard Q COVID-19 Rapid Antigen Test and Simulation of its Real-World Application in Korea", Annals of Laboratory Medicine, 41(6), pp.588~592 (2021), 대한진단검사의학회[DOI]
- Rutjes AW, "Case-control and two-gate designs in diagnostic accuracy studies", Clin Chem, 51, pp.1335~1341 (2005)
- Ki Ho Hong, "Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea", Annals of Laboratory Medicine, 40(5), pp.351~360 (2020), 대한진단검사의학회[DOI]
- Heungsup Sung, "COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays", Annals of Laboratory Medicine, 40(6), pp.439~447 (2020), 대한진단검사의학회[DOI]
- Hur KH, "Evaluation of four commercial kits for SARS-CoV-2 real-time reverse-transcription polymerase chain reaction approved by emergency-use-authorization in Korea", Front Med(Lausanne), 7, pp.521~ (2020)
- "Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK" (2020)[URL]
- "Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays" (2020)[URL]
- Mason PE, "The hydration structure of guanidinium and thiocyanate ions : implications for protein stability in aqueous solution", Proc Natl Acad Sci U S A, 100, pp.4557~4561 (2003)